Summary:
We studied long-term pulmonary function testing (PFT) in a retrospective cohort of 6-month survivors of allogeneic marrow transplant (BMT) between 1980 and 1997. Of 593 patients, 73, 71 and 65% had adequate data to assess for obstruction, restriction and diffusion impairments respectively. Over 5 years, mean declines in 1-s forced expiratory volume/forced vital capacity (FEV1/FVC), total lung capacity (TLC) and diffusion were 4, 7 and 17%, respectively. TLC and diffusion tended to subsequently increase. In all, 6, 12 and 35% of patients met criteria for obstruction, restriction and impaired diffusion, respectively. Obstruction was less common in recent transplants (5 vs 15%, P=0.004), while restriction and diffusion impairment rates remained stable. There was significantly greater mortality with obstruction (HR 2.0 (1.04–3.95)), and a nonstatistically significant higher mortality rate with restriction (HR 1.6 (0.95–2.75)), but not with impaired diffusion (HR=0.99 (0.65–1.50)). cGVHD (OR 16.7 (2.2–129.8)) and busulfan (OR 2.9 (1.01–8.24)) were associated with obstruction. Marrow from nonsibling or mismatched donors (OR 4.9 (2.2–10.7)) was associated with restriction. In summary, after BMT, decreased diffusion capacity is common and benign; obstruction has decreased in frequency, is rare without cGVHD, and is associated with mortality; nonsibling and mismatched donor are risk factors for restriction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Quabeck K . The lung as a critical organ in marrow transplantation. Bone Marrow Transplant 1994; 14 (Suppl 4): S19–S28.
Breuer R, Lossos IS, Berkman N, Or R . Pulmonary complications of bone marrow transplantation. Resp Med 1993; 87: 571–579.
Afessa B, Litzow MR, Tefferi A . Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425–434.
Crawford SW, Pepe M, Lin D et al. Abnormalities of pulmonary function tests after marrow transplantation predict nonrelapse mortality. Am J Resp Crit Care Med 1995; 152: 690–695.
Chan CK . Bone marrow transplantation bronchiolitis obliterans. In Epler GR (ed). Diseases of the Bronchioles. Raven Press: New York, 1994, pp 247–257.
Marras TK, Szalai JP, Chan CK et al. Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument. Bone Marrow Transplant 2002; 30: 599–607.
Estenne M, Maurer J, Boehler A et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297–310.
American Thoracic Society Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique–1995 update. Am J Resp Crit Care Med 1995; 152: 2185–2198.
Steyerberg EW, Eijkemans MJ, Harrell Jr FE, Habbema JD . Prognostic modeling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stati Med 2000; 19: 1059–1079.
Stiell IG, Greenberg GH, McKnight RD et al. A study to develop clinical decision rules for the use of radiography in acute ankle injuries. Ann Emergency Med 1992; 21: 384–390.
Harrell FE, Lee KL, Mark DB . Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stati Med 1996; 15: 361–387.
Hanley JA, McNeil BJ . A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839–843.
Payne L, Chan CK, Fyles G et al. Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation. Chest 1993; 104: 114–118.
Duncker C, Dohr D, Von Harsdorf S et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplant 2000; 25: 1263–1268.
Acknowledgements
We thank Dr Smita Pakhale, Ms Jessica Wright and the late Dr Usha Senitharajah for help with data collection and entry, and Dr Robert Hyland and Dr Michael Hutcheon for sharing their content expertise. Dr Marras is a Canadian Institutes of Health Research and Canadian Thoracic Society postdoctoral fellow and University of Toronto, Department of Medicine clinician scientist trainee. Dr Laupacis is a Senior Scientist of the Canadian Institutes of Health Research. The Ontario Thoracic Society supported this project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marras, T., Chan, C., Lipton, J. et al. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 33, 509–517 (2004). https://doi.org/10.1038/sj.bmt.1704377
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704377
Keywords
This article is cited by
-
Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era
Current Oncology Reports (2019)
-
Decreased pulmonary function in asymptomatic long-term survivors after allogeneic hematopoietic stem cell transplant
Bone Marrow Transplantation (2016)
-
Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options
Bone Marrow Transplantation (2012)
-
Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
Bone Marrow Transplantation (2011)
-
Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation
Bone Marrow Transplantation (2008)